China Biotech Services Holdings Limited

SEHK:8037 株式レポート

時価総額:HK$429.3m

China Biotech Services Holdings 過去の業績

過去 基準チェック /06

China Biotech Services Holdingsは17.5%の年平均成長率で業績を伸ばしているが、Healthcare業界はgrowingで11.8%毎年増加している。売上は成長しており、年平均20.8%の割合である。

主要情報

17.5%

収益成長率

17.7%

EPS成長率

Healthcare 業界の成長11.3%
収益成長率20.8%
株主資本利益率-62.6%
ネット・マージン-233.4%
前回の決算情報30 Jun 2024

最近の業績更新

Recent updates

China Biotech Services Holdings Limited's (HKG:8037) 28% Share Price Plunge Could Signal Some Risk

Aug 12
China Biotech Services Holdings Limited's (HKG:8037) 28% Share Price Plunge Could Signal Some Risk

Some Shareholders Feeling Restless Over China Biotech Services Holdings Limited's (HKG:8037) P/S Ratio

Jun 26
Some Shareholders Feeling Restless Over China Biotech Services Holdings Limited's (HKG:8037) P/S Ratio

China Biotech Services Holdings Limited's (HKG:8037) Popularity With Investors Under Threat As Stock Sinks 31%

Mar 07
China Biotech Services Holdings Limited's (HKG:8037) Popularity With Investors Under Threat As Stock Sinks 31%

Earnings Not Telling The Story For China Biotech Services Holdings Limited (HKG:8037) After Shares Rise 46%

Jan 18
Earnings Not Telling The Story For China Biotech Services Holdings Limited (HKG:8037) After Shares Rise 46%

We Think China Biotech Services Holdings (HKG:8037) Might Have The DNA Of A Multi-Bagger

Jan 06
We Think China Biotech Services Holdings (HKG:8037) Might Have The DNA Of A Multi-Bagger

Does China Biotech Services Holdings (HKG:8037) Have A Healthy Balance Sheet?

Dec 09
Does China Biotech Services Holdings (HKG:8037) Have A Healthy Balance Sheet?

These 4 Measures Indicate That China Biotech Services Holdings (HKG:8037) Is Using Debt Safely

Aug 24
These 4 Measures Indicate That China Biotech Services Holdings (HKG:8037) Is Using Debt Safely

A Look At The Fair Value Of China Biotech Services Holdings Limited (HKG:8037)

Nov 05
A Look At The Fair Value Of China Biotech Services Holdings Limited (HKG:8037)

Is China Biotech Services Holdings (HKG:8037) A Risky Investment?

Oct 13
Is China Biotech Services Holdings (HKG:8037) A Risky Investment?

What China Biotech Services Holdings Limited's (HKG:8037) 35% Share Price Gain Is Not Telling You

Jun 28
What China Biotech Services Holdings Limited's (HKG:8037) 35% Share Price Gain Is Not Telling You

China Biotech Services Holdings (HKG:8037) Could Become A Multi-Bagger

Mar 16
China Biotech Services Holdings (HKG:8037) Could Become A Multi-Bagger

China Biotech Services Holdings (HKG:8037) Knows How To Allocate Capital Effectively

Dec 01
China Biotech Services Holdings (HKG:8037) Knows How To Allocate Capital Effectively

Under The Bonnet, China Biotech Services Holdings' (HKG:8037) Returns Look Impressive

Jul 26
Under The Bonnet, China Biotech Services Holdings' (HKG:8037) Returns Look Impressive

China Biotech Services Holdings' (HKG:8037) Robust Earnings Are Supported By Other Strong Factors

Apr 05
China Biotech Services Holdings' (HKG:8037) Robust Earnings Are Supported By Other Strong Factors

Investors Shouldn't Overlook China Biotech Services Holdings' (HKG:8037) Impressive Returns On Capital

Mar 23
Investors Shouldn't Overlook China Biotech Services Holdings' (HKG:8037) Impressive Returns On Capital

Did You Miss China Biotech Services Holdings' (HKG:8037) Whopping 825% Share Price Gain?

Feb 23
Did You Miss China Biotech Services Holdings' (HKG:8037) Whopping 825% Share Price Gain?

Chun-Shun Ko Just Bought 27% More Shares In China Biotech Services Holdings Limited (HKG:8037)

Jan 28
Chun-Shun Ko Just Bought 27% More Shares In China Biotech Services Holdings Limited (HKG:8037)

What Is The Ownership Structure Like For China Biotech Services Holdings Limited (HKG:8037)?

Jan 11
What Is The Ownership Structure Like For China Biotech Services Holdings Limited (HKG:8037)?

The Trend Of High Returns At China Biotech Services Holdings (HKG:8037) Has Us Very Interested

Dec 08
The Trend Of High Returns At China Biotech Services Holdings (HKG:8037) Has Us Very Interested

収支内訳

China Biotech Services Holdings の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。


収益と収入の歴史

SEHK:8037 収益、費用、利益 ( )HKD Millions
日付収益収益G+A経費研究開発費
30 Jun 2462-1451620
31 Mar 2498-1201510
31 Dec 23212-951520
30 Sep 23776332100
30 Jun 231,3471592390
31 Mar 231,5982082450
31 Dec 221,8522582590
30 Sep 221,394742220
30 Jun 2293732040
31 Mar 22854531900
31 Dec 21624191690
30 Sep 216141131590
30 Jun 219991551570
31 Mar 21797541530
31 Dec 20656301440
30 Sep 20564-211300
30 Jun 2062-1051150
31 Mar 2058-1061130
31 Dec 1959-991040
30 Sep 1962-761030
30 Jun 1965-721010
31 Mar 1967-66950
31 Dec 1870-64960
30 Sep 1875-95910
30 Jun 1879-83800
31 Mar 1888-48730
31 Dec 17105-63690
30 Sep 17111-48610
30 Jun 17113-64640
31 Mar 17104-103710
31 Dec 1687-86730
30 Sep 1669-81720
30 Jun 1652-84620
31 Mar 1639-72500
31 Dec 1534-54440
30 Sep 153-36190
30 Jun 1538-21270
31 Mar 1556-43350
31 Dec 1470-75470
30 Sep 14111-85750
30 Jun 1492-84730
31 Mar 1489-79690
31 Dec 1385-60590

質の高い収益: 8037は現在利益が出ていません。

利益率の向上: 8037は現在利益が出ていません。


フリー・キャッシュフローと収益の比較


過去の収益成長分析

収益動向: 8037は利益を出していないが、過去 5 年間で年間17.5%の割合で損失を削減してきた。

成長の加速: 8037の過去 1 年間の収益成長を 5 年間の平均と比較することはできません。現在は利益が出ていないためです。

収益対業界: 8037は利益が出ていないため、過去 1 年間の収益成長をHealthcare業界 ( -16.9% ) と比較することは困難です。


株主資本利益率

高いROE: 8037は現在利益が出ていないため、自己資本利益率 ( -62.6% ) はマイナスです。


総資産利益率


使用総資本利益率


過去の好業績企業の発掘